A detailed history of Sterling Capital Management LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Sterling Capital Management LLC holds 1,612 shares of NBIX stock, worth $185,412. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,612
Previous 1,823 11.57%
Holding current value
$185,412
Previous $210 Million 4.76%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

SELL
$111.62 - $139.44 $23,551 - $29,421
-211 Reduced 11.57%
1,612 $220 Million
Q3 2024

Nov 12, 2024

BUY
$114.58 - $153.15 $208,879 - $279,192
1,823 New
1,823 $210 Million

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Sterling Capital Management LLC Portfolio

Follow Sterling Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sterling Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sterling Capital Management LLC with notifications on news.